NORTHERA

This brand name is authorized in United States.

Active ingredients

The drug NORTHERA contains one active pharmaceutical ingredient (API):

`1`	Droxidopa UNII `J7A92W69L7` - DROXIDOPA
	Droxidopa is a synthetic amino acid analog that is directly metabolized to norepinephrine by dopa-decarboxylase, which is extensively distributed throughout the body. Droxidopa is believed to exert its pharmacological effects through norepinephrine and not through the parent molecule or other metabolites. The exact mechanism of action of droxidopa in the treatment of neurogenic orthostatic hypotension is unknown.
	Read more about Droxidopa

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
NORTHERA Capsule	MPI, US: SPL/PLR	FDA, National Drug Code (US)

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
US	FDA, National Drug Code	67386-820, 67386-821, 67386-822

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.